Breast

Prostate & urology

Lung & pleura

Colorectal & gastro

Melanoma & skin

Head & neck

Ovary & gynaecology

+ -

News

ecancer sources relevant oncology news from key institutes, journals, governments, NGOs and charities, along with commissioned pieces from our dedicated news team.

SABCS 2019: Oral paclitaxel yielded better outcomes than intravenous paclitaxel for metastatic breast cancer patients in phase III trial

SABCS 2019: Oral paclitaxel yielded better outcomes than intravenous paclitaxel for metastatic breas...

SABCS 2019: Residual cancer burden can predict outcomes for patients with any breast cancer type

SABCS 2019: Residual cancer burden can predict outcomes for patients with any breast cancer type

SABCS 2019: Long-term follow-up shows oestrogen alone and oestrogen plus progestinHave opposite effects on breast cancer incidence in postmenopausal women

SABCS 2019: Long-term follow-up shows oestrogen alone and oestrogen plus progestinHave opposite effe...

SABCS 2019: Circulating tumour DNA may help predict recurrence in patients with early triple-negative breast cancer

SABCS 2019: Circulating tumour DNA may help predict recurrence in patients with early triple-negativ...

Breast cancer cells swallow a 'free lunch' of dietary fat particles from the bloodstream

Breast cancer cells swallow a 'free lunch' of dietary fat particles from the bloodstream

SABCS 2019: Extended letrozole therapy improves disease-free survival in postmenopausal women with HR-positive breast cancer

SABCS 2019: Extended letrozole therapy improves disease-free survival in postmenopausal women with H...

SABCS 2019: MINDACT trial data reveal certain women with luminal breast cancer may be undertreated with tamoxifen alone

SABCS 2019: MINDACT trial data reveal certain women with luminal breast cancer may be undertreated w...

SABCS 2019: Partial breast irradiation may be as effective as whole breast irradiation in preventing recurrence in patients with early breast cancer

SABCS 2019: Partial breast irradiation may be as effective as whole breast irradiation in preventing...

SABCS 2019: Adding tucatinib to drug combination extends survival for advanced HER2-positive breast cancer patients

SABCS 2019: Adding tucatinib to drug combination extends survival for advanced HER2-positive breast ...

SABCS 2019: Neoadjuvant and adjuvant treatment with pembrolizumab improves pathologic complete response rates for patients with triple-negative breast cancer with lymph node involvement

SABCS 2019: Neoadjuvant and adjuvant treatment with pembrolizumab improves pathologic complete respo...

Tweets by @ecancer

More from ecancer